FDA Issues Three 510(k) Clearances for New MRI Offerings from GE HealthCare

The Food and Drug Administration has granted three 510(k) clearances for the SIGNA One AI-enabled modality for MRI workflows, the SIGNA Bolt 3T MRI system and the 1.5T SIGNA Sprint with Freelium MRI platform from GE HealthCare.

The 1.5T SIGNA Sprint MRI offers improved image quality and deep learning features across a wide range of clinical applications with helium-free technology, according to GE HealthCare. The company noted that the SIGNA Sprint MRI also provides greater than a five-hour ride-through time in the event of power outages.

GE HealthCare said the SIGNA Bolt platform also emphasizes sustainability with an 80/200 gradient system delivering performance at 30 percent lower power consumption in contrast to older generation devices. Additionally, GE HealthCare noted that SIGNA Bolt offers feet-first capabilities for patients with claustrophobia concerns.

The SIGNA One modality facilitates patient comfort with the SIGNA One Table, real-time, touchscreen guidance for technologists on patient positioning, and contactless respiratory and peripheral gating, according to GE HealthCare.

“As MRI demand continues to rise across clinical areas, providers need solutions that deliver greater efficiency without compromising diagnostic precision. With this new SIGNA generation, we’re redefining what’s possible – aiming to bring smarter, faster, more sustainable and more consistent imaging to more patients, across more settings, with confidence,” noted Kelly Londy, the president and CEO of MR at GE HealthCare.